Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Cancer Cytopathology|November 3, 2015
Branched-chain in situ hybridization for κ and λ light chains: A powerful ancillary technique for determining B-cell clonality in cytology samplesKshitij Arora, Ivan Chebib, Lawrence Zukerberg, et al.Journal of Cutaneous Pathology|May 21, 2010
Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarksRobert Loewe, Darryl A Oble, Teresa Valero, et al.Gastrointestinal Endoscopy|September 16, 2022
Incidence and natural history of gastric high-grade dysplasia in patients with familial adenomatous polyposis syndromeMarisa DelSignore, Tiffany Jeong, Grant Denmark, et al.Human Pathology|October 25, 2016
Clinicopathological characteristics of invasive gastric Helicobacter pyloriJonathan Dudley, Tad Wieczorek, Martin Selig, et al.The American Journal of Surgical Pathology|August 19, 2004
Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumorsVikram Deshpande, Carlos Fernandez-del Castillo, Alona Muzikansky, et al.The American Journal of Surgical Pathology|September 5, 2020
IgG4-related Lymphadenopathy: A Comparative Study of 41 Cases Reveals Distinctive Histopathologic FeaturesJacob R Bledsoe, Judith A Ferry, Azfar Neyaz, et al.The American Journal of Pathology|February 26, 2004
The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancerChuanwei Yang, Viviana Ionescu-Tiba, Karen Burns, et al.The American Journal of Surgical Pathology|January 27, 2007
Lymphoma of the ocular adnexa: A study of 353 casesJudith A Ferry, Claire Y Fung, Lawrence Zukerberg, et al.Hepatology (Baltimore, Md.)|February 22, 2005
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesisYoshitaka Kamegaya, Yoichi Hiasa, Lawrence Zukerberg, et al.Mabs|February 5, 2014
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft modelsKathleen R Whiteman, Holly A Johnson, Michele F Mayo, et al.Pageof 4